Low cholesterol linked with worse survival in patients with kidney cancer

June 12, 2014

People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.

Increasing evidence suggests that alterations in and other lipids are associated with the development, progression, and prognosis of various cancers. To assess the situation as it relates to , Tobias Klatte, MD, of the Medical University of Vienna in Austria, and his colleagues analyzed total blood cholesterol levels in 867 patients with renal cell carcinoma before they underwent kidney surgery. The investigators then followed the patients for a median of 52 months.

Low before treatment was associated with more advanced tumor stages and cancer spread during follow-up. Also, patients with high cholesterol had a 43 percent lower risk of dying from their cancer compared with patients with low cholesterol. Finally, including patients' cholesterol levels with traditional risk factors increased the accuracy of prognoses.

It's unclear how cholesterol may affect a kidney cancer patients' prognosis. It may be that certain components of cholesterol impact the activity of cancer-related pathways to affect tumor growth and spread.

"As this was a hypothesis-generating study, our findings should be confirmed in independent datasets. If confirmed, patients with may be considered high-risk and may be treated or followed up more aggressively," said Dr. Klatte.

Explore further: LDL cholesterol is a poor marker of heart health in patients with kidney disease

More information: "Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma." Michela de Martino, Carmen V. Leitner, Christoph Seemann, Sebastian L. Hofbauer, Ilaria Lucca, Andrea Haitel, Shahrokh F. Shariat, and Tobias Klatte. BJU International; Published Online: June 12, 2014 (DOI: 10.1111/bju.12767).

Related Stories

Cholesterol plays a key role in cell migration

May 22, 2014

University of Barcelona's researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona (UB) and CELLEX Biomedical ...

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.